Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Biogen Inc.’s Chief Executive Officer is searching for smaller deals to expand its treatment portfolio as the company prepares for a future that he expects will be highly dependent on Alzheimer’s disease drugs.

Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps UpSlovak Premier’s Condition Stable But Serious, Minister SaysSupreme Court Upholds Consumer Watchdog's FundingCalifornia’s Billionaire-Backed City Gets Promise of First JobsTop HSBC Shareholder Ping An Exploring Ways to Cut $13 Billion StakeFed’s Mester Suggests Interest Rates Should Stay High for LongerRenaissance Technologies Piled Into GameStop, AMC Ahead of RallyCanada and U.S.

1% in MarchCanada's economy faces 'mismatch' between employers and newcomers: CEOThe Daily Chase: Energy sector bracing for wildfire threatThe Daily Chase: TSX at all-time highs, Canada jobs number surpasses expectationsThe Daily Chase: Shopify plunges on surprise loss, warns of thinner marginsThe Daily Chase: Labour talks going different directions at WestJet and NestleLula Pushes New Petrobras CEO to Boost Refinery, Gas InvestmentsEU Tracking ‘Spread of Disinformation’ on Slovak...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines